Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

This publication has 26 references indexed in Scilit:

• Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction
  European Heart Journal, 2007
• Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
  New England Journal of Medicine, 2007
• Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
  New England Journal of Medicine, 2007
• Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
  JACC, 2006
• Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions
  Circulation, 2006
• Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
  JACC, 2005
• Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial
  Circulation, 2004
• A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
  New England Journal of Medicine, 2004
• TAXUS III Trial
  Circulation, 2003
• A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
  New England Journal of Medicine, 2002